Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Research Shows Some Gallbladder Removals May Not Be Necessary

By HospiMedica International staff writers
Posted on 20 Apr 2017
Most patients hospitalized with acute biliary pancreatitis that decline immediate cholecystectomy fare well during follow-up, according to a new study.

Researchers at Johns Hopkins University and the University of Pittsburgh Medical Center conducted a study to examine patient’s adherence to the current guidelines for mild-to-moderate acute biliary pancreatitis, which recommend cholecystectomy during or within four weeks of hospitalization. More...
Patients who followed cholecystectomy guidelines, as well as those who did not, were compared for subsequent hospitalization for acute or chronic pancreatitis, adjusted for age, sex, comorbidities, and length of index hospital stay.

The results showed that of the 17,010 patients who met the inclusion criteria, 78% were adherent with the guidelines, including 10,918 who underwent cholecystectomy during the index hospitalization and 2,387 who underwent cholecystectomy within 30 days. Of the 3,705 patients who did not adhere to the guidelines, only 1,213 (or less than 10%) had a cholecystectomy within six months. The majority of those who did not have the surgery within 30 days had still not had one done four years later. The study was published in the March 2017 issue of The American Journal of Gastroenterology.

“These findings tell us that there may be a way to avoid gallbladder removal surgery; as medicine evolves, it is important to reflect on opportunities to refine care further,” said lead author Susan Hutfless, PhD, of JHU. “The personalization of cholecystectomy timing is still a hypothesis and would need to be tested in rigorous studies. For now, there is clear evidence that the guidelines are beneficial to patients and should be followed.”

Cholecystectomy is the surgical removal of the gallbladder. The most common cause is cholelithiasis, resulting from gallstones trapped inside the gallbladder duct that trigger an intense abdominal pain that usually lasts between one and five hours. Surgical options include laparoscopic cholecystectomy, in which four incisions are made in the abdomen - one on the rim of the navel, one beneath the navel, and two beneath the navel and to the right; single-incision laparoscopic cholecystectomy (SILC); and the more invasive open cholecystectomy. The surgery can lead to post-cholecystectomy syndrome.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.